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Abstract
Introduction Identification of bacterial infections is crucial if
treatment is to be initiated early and antibiotics used rationally.
The primary objective of this study was to test the efficiency of
procalcitonin (PCT) in identifying bacterial/parasitic episodes
among febrile adult patients presenting to an emergency
department. Secondary objectives were to identify clinical or
biological variables associated with either bacterial/parasitic
infection or critical illness.
Methods This was a prospective, single centre, non-
interventional study, conducted in the adult emergency
department of an academic tertiary care hospital. We included
patients with body temperature of 38.5°C or greater. A serum
sample for measurement of PCT was collected in the
emergency room. Patients were followed up until day 30. After
reviewing the medical files, two independent experts, who were
blind to the PCT results, classified each of the patients as having
a bacterial/parasitic infection, viral infection, or another
diagnosis.
Results Among 243 patients included in the study, 167 had
bacterial/parasitic infections, 35 had viral infections and 41 had
other diagnoses. The PCT assay, with a 0.2 μg/l cutoff value,
had a sensitivity of 0.77 and a specificity of 0.59 in diagnosing
bacterial/parasitic infection. Of the patients with PCT 5 μg/l or
greater, 51% had critical illness (death or intensive care unit
admission) as compared with 13% of patients with lower PCT
values.
Conclusion Bearing in mind the limitations of an observational
study design, the judgements of the emergency department
physicians were reasonably accurate in determining the pretest
probability of bacterial/parasitic infection. PCT may provide
additional, valuable information on the aetiology and prognosis
of infection in the emergency department.
Introduction
Accurate identification of bacterial aetiology of fever in
patients attending the emergency department (ED) is a desir-
able objective but it is often unattainable, largely because
signs and symptoms of bacterial and viral infections overlap
considerably. Delay in identifying pathogens from specimen
cultures adds to the difficulty in establishing an aetiological
diagnosis in the ED and leads to inappropriate use of antibiot-
ics. In addition, estimation of the severity of bacterial infection
is mostly based on the presence of characteristics suggestive
of systemic inflammatory response syndrome, which may not
be apparent when the patient is seen early in the course of the
infection.
Procalcitonin (PCT) concentration is raised in the serum of
patients with severe bacterial infection [1-4]. The primary
objective of our study was to test the efficiency of PCT in iden-
tifying bacterial/parasitic episodes among febrile adult
CI = confidence interval; ED = emergency department; ICU = intensive care unit; PCT = procalcitonin; ROC = receiver operating characteristic.Critical Care    Vol 11 No 3    Hausfater et al.
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patients presenting to an ED. Secondary objectives were to
identify clinical or biological variables associated with either
bacterial or parasitic infection, and to identify clinical or biolog-
ical variables associated with critical illness during the febrile
episode.
Materials and methods
Patients
Patients were eligible for inclusion in this prospective study if
they presented, during the period from 1 June 2003 to 29 Feb-
ruary 2004, with a oral temperature of 38.5°C or greater to the
adult ED of a 1800-bed academic tertiary care hospital.
Patients younger than 15 years were excluded. Immunocom-
promised status was not an exclusion criterion. The study was
approved by the ethical committee of our hospital (Comité de
Protection des Personnes Pitié-Salpêtrière, Paris, France). All
patients gave written informed consent.
After evaluation in the emergency room, each patient was
examined by a senior physician. Blood sampling and radiolog-
ical examinations were ordered in accordance with routine
care apart from blood chemistry, which in all patients included
a sample for PCT measurement. Microbiological work up var-
ied according to infectious clinical focus but included, in all
patients, one pair of blood culture and urinary analysis. The
emergency physician completed a standardized form for each
patient, including co-morbidity, vital signs, putative source of
infection, prior antibiotic therapy before ED consultation, and
presence or absence of headache, abdominal pain, diarrhoea,
myalgia, sore throat, rhinorrhoea, dry cough, polyadenopathy
and rash. The form ended with the emergency physician's
diagnostic suspicion, antibiotic prescription and patient
course (not admitted or admitted to a medical, surgical, or
intensive care unit [ICU] bed). PCT results were not available
at this time.
All patients were followed up by study investigators at 8 and
30 days, either via hospital medical files or after a telephone
call in those patients not admitted or with short hospital stay.
Follow-up assessment included the following factors: fever
resolution (either spontaneously or with antibiotics), change in
final diagnosis, occurrence of another infectious phase or hos-
pital stay, and outcome (deceased or alive).
Two independent experts, who were blind to the PCT results,
reviewed each complete medical history and categorized
patients into one of three groups: bacterial or parasitic infec-
tion; viral infection; or other. In case of disagreement between
the two experts, consensus was reached with a third expert.
Bacterial and parasitic infections were pooled together
because both are associated with significant elevations in
PCT levels as compared with viral infections. The category
'other' included non-infectious aetiologies of fever. The viral
category was divided into acute (for instance, influenza) and
chronic (for example, HIV, or hepatitis B or C virus) viral infec-
tions. The febrile episode was attributed by experts to a viral
aetiology for all cases of acute viral infection. Chronic viral
infection was retained as the aetiology of febrile episode after
all other causes of fever had been ruled out.
This classification by the experts was considered the 'gold
standard' for fever aetiology, against which PCT measurement
was evaluated.
Procalcitonin assay
For serum PCT measurement, we used a time-resolved ampli-
fied cryptate emission technology assay (Kryptor PCT,
Brahms, Hennigsdorf, Germany). This assay is based on a pol-
yclonal antibody against calcitonin and a monoclonal antibody
against katacalcin, which bind to the calcitonin and katacalcin
sequence of precursor molecules. This assay has an optimized
functional sensitivity of 0.06 μg/l. In healthy volunteers, normal
PCT levels are under 0.1 μg/l. Based on previous studies
involving ED patients, we chose a cutoff of 0.2 μg/L for the
PCT assay [2,5].
Statistical analysis
Data are expressed as mean ± standard deviation or median
and 95% confidence interval (CI) for non-Gaussian distribu-
tions. Comparison of two means was performed using the Stu-
dent's  t-test, comparison of two medians using the Mann-
Whitney test, and comparison of two proportions using the
Fisher's exact method.
Sensitivity, specificity, positive and negative predictive values,
and accuracy (defined as the sum of concordant cells divided
by the sum of all cells in a 2 × 2 table) and their 95% CIs were
calculated. Comparisons of these diagnostic variables
between PCT and emergency physician were performed using
the CI method.
We assessed the associations between various variables,
including the diagnosis suspected by the emergency physi-
cian, elevated PCT, and the final diagnosis of the experts (bac-
terial/parasitic and viral infection) using a stepwise forward
logistic regression. We also entered all variables with a univar-
iate P value below 0.05 into the model. We considered varia-
bles with a multivariate P value below 0.05 to be independent
indicators of bacterial/parasitic infection and retained them in
the model. Continuous variables were transformed into dichot-
omous variables using the receiver operating curve (ROC);
specifically, we determined the optimal threshold that mini-
mized the distance to the ideal point (sensitivity = specificity =
1) on the ROC curve. The discrimination ability of the final
model was quantified by using the area under the ROC curve
with its 95% CI. The calibration of the final model was
assessed using the Hosmer-Lemeshow goodness-of-fit test.
The same procedure was applied to determine the variables
associated with critical illness, defined as admission into an
ICU or death within 30 days.Available online http://ccforum.com/content/11/3/R60
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All statistical comparisons were two-tailed, and a P value of
less than 0.05 was required to reject the null hypothesis. Sta-
tistical analysis was performed using a computer and NCSS
2001 software (Statistical Solutions Ltd, Corke, Ireland).
Results
The flow diagram of the study is depicted in Figure 1. Among
the 19,460 atraumatic patients who were examined in our ED
during the study period, we included 253 (1.3%) consecutive
febrile patients. Ten patients were excluded from the analysis
because PCT samples were lacking. Baselines characteristics
of the remaining 243 patients were as follows: 134 were male
and 109 were female, and the mean age was 56 ± 21 years.
Seventy-one patients (29%) were immunocompromised: 22
patients were being treated for solid organ tumours, 19 had
chronic HIV infection, 17 were being treated for malignant
haemopathy, five had undergone solid organ transplantation,
three were on immunosuppressive therapy, two were on corti-
costeroid therapy, two had undergone splenectomy and one
had Down's syndrome. Thirty-two patients (13%) were receiv-
ing antibiotics when they presented at the ED. Overall, 196
(81%) patients were admitted to hospital (median duration 7
days, 95% CI 6 to 8 days), of which 31 (13%) were admitted
to the ICU (immediately after ED evaluation in 24 patients and
during the first 48 hours in seven). Blood culture was per-
formed in 237 (98%) patients, and of these 42 (18%) cultures
exhibited growth of pathogenic micro-organisms (Gram posi-
tive, 21; Gram negative, 21; both Gram positive and negative,
2). The majority of patients (83%) left the ED with an antibiotic
prescription. Twenty-three patients (10%) were deceased on
day 8, and 30 (13%) patients were deceased on day 30.
According to the expert classification, 167 (69%) patients had
bacterial/parasitic infection, including 17 with concomitant
chronic viral infection, and two with secondary influenza infec-
tion. Thirty-five patients (14.5%) had a viral infection; in 33 of
these patients the infection was acute and in two it was
chronic (without an alternative aetiology for the fever). A total
of 41 patients were deemed to be in the 'other' category,
including 24 patients with environmental heatstroke (four with
chronic viral infection), two with acute pancreatitis, and one
patient with haemophagocytic syndrome. Parasitic infections
were malaria (in 12 patients) and Pneumocystis carinii pneu-
monia (in one patient). The main diagnoses of the patients are
summarized in Table 1. Agreement between the two experts
occurred in 89% of cases for the diagnosis of bacterial/para-
sitic infection and in 93% of cases for the diagnosis of viral
infection.
Diagnosis of bacterial/parasitic infection
PCT concentrations were above 0.2 μg/l in 128 out of 173
(74%) patients with bacterial/parasitic infections. The diag-
nostic performance of PCT is shown and compared with that
of the emergency physician in Table 2. For PCT, the area
under ROC curve was 0.766 (95% CI 0.697 to 0.821; P <
0.001) for the diagnosis of bacterial/parasitic infection. Indi-
vidual values for PCT and C reactive protein are represented
in Figure 2. Based on the ROC curve, the optimal threshold for
PCT was confirmed to be 0.2 μg/l. When the subgroup of
patients with positive blood cultures or positive Plasmodium
thick smear tests was considered, PCT had a sensitivity of
0.87 (95% CI 0.76 to 0.94), a specificity of 0.41 (95% CI 0.34
to 0.48), a positive predictive value of 0.30 (95% CI 0.24 to
0.38) and a negative predictive value of 0.92 (95% CI 0.83 to
0.96). The accuracy of PCT was found to be 0.50 (95% CI
0.44 to 0.56) in predicting bloodstream infection.
Patients with bacterial infection who were receiving antibiotics
when attending the ED were compared with patients who
were not. Total white blood cell count, neutrophil leucocytes
and C-reactive protein values did not differ significantly
between groups. Median PCT concentrations were similar in
both groups, at 0.78 μg/l (95% CI 0.49 to 3.80 μg/l) and 0.79
Figure 1
Study design flow diagram and outcomes Study design flow diagram and outcomes. F, female; M, male; PCT, 
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μg/l (95% CI 0.56 to 1.47 μg/l), respectively (not significant).
The percentage of patients with elevated PCT did not differ
significantly between groups (77% versus 76%).
Finally, immunocompromised patients were compared with
the immunocompetent group. First, there was no difference
between the number of bacterial/parasitic episodes (accord-
ing to expert classification) in the two groups, at 51 (72%) ver-
sus 116 (67%), respectively (P = 0.55, not significant). The
PCT area under ROC curve was not statistically different
between immunocompromised and immunocompetent
groups, at 0.792 (95% CI 0.654 to 0.879) and 0.759 (95%
CI 0.673 to 0.854), respectively (P = 0.63, not significant).
However, PCT values were significantly higher in immunocom-
promised than in immunocompetent patients, at 1.85 μg/l
(95% CI 0.67 to 4.70 μg/l) versus 0.61 μg/l (95% CI 0.38 to
1.10 μg/l; P = 0.005), respectively, for patients with bacterial/
parasitic infection, and 0.26 μg/l (95% CI 0.15 to 0.5 μg/l)
Table 1
Main clinical diagnoses of the 243 patients established after expert evaluation (blinded to PCT results)
Major diagnosis Number of patients (%) Aetiology (n [%])
Bacterial Viral Parasitic
Infection 202 (83) 154 (76) 35 (17) 13 (7)
Respiratory tract infection 69 (28) 62 (90) 6 (8.5) 1 (1.5)
Urinary tract infection 42 (21) 42 - -
Digestive tract infection 19 (9.4) 15 (79) 4 (21) -
Flu-like 14 (7) - 14 -
Malaria 12 (6) - - 12
Bacteraemia of unknown origin 12 (6) 12 - -
Ear nose and throat infection 9 (4.5) 5 (55) 4 (45) -
Wound and soft tissue infection 7 (3.5) 7 0 -
Bone and joint infection 3 (1.5) 3
Peritonitis 3 (1.5) 3 0 -
Viral meningitis 4 (1.3) - 4 -
Purulent meningitis 2 (2) 2 - -
Endocarditis 2 (2) 2 - -
Brucellosis 1 (0.5) 1 - -
Chronic viral infection 2 (2) - 2 -
Herpes simplex 1 (0.5) - 1 -
Non-infectious febrile episodes 41 (17)
Febrile neutropenia and 7 - - -
Neoplasic fever
Heatstroke 24 - - -
FUO 3 - - -
Acute pancreatitis 2 - - -
Haemophagocytic syndrome 1 - - -
Alcoholic hepatitis 1 - - -
Systemic vasculitis 1 - - -
Drug hypersensitivity syndrome 1 - - -
Acute appendicitis 1 - - -
Total 243 (100)
FUO, fever of unknown origin; PCT, procalcitonin.Available online http://ccforum.com/content/11/3/R60
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versus 0.11 (95% CI 0.05 to 0.14; P = 0.01) for patients with-
out bacterial/parasitic infection.
Stepwise logistic regression analysis showed four independ-
ent variables to be significantly associated with a diagnosis of
bacterial/parasitic infection (Table 3): emergency physician
suspicion, C-reactive protein over 40 mg/l, neutrophil leuco-
cytes over 7,500/mm3, and PCT over 0.2 μg/l (Table 3).
Among 173 patients with bacterial/parasitic infection (accord-
ing to emergency physician diagnosis), antibiotic treatment
was not initiated in emergency room in nine (5%) patients,
although five of them had positive PCT values, including three
with positive blood cultures. Conversely, among the 20
patients with acute viral infection according to the emergency
physician diagnosis, seven (35%) were given antibiotics.
Prediction of critical illness
At 30 days of follow up, 55 patients presented with critical ill-
ness (31 admissions to the ICU and 30 deaths, including six
patients admitted to the ICU). Two of the six patients with
bacterial infections, initially admitted to a medical bed and
transferred within the 48 subsequent hours to the ICU, had a
PCT level above 5 μg/l (8.53 μg/l and 282 μg/l). Similarly,
three patients with bacterial infection were initially admitted to
a medical bed and died suddenly before day two. None of
these patients had co-morbidity that could have restricted ICU
transfer (for instance, end-stage cancer or severe neurode-
generative disease) and all three had PCT concentrations
above 5 μg/l (5.8, 36 and 316 μg/l). Univariate analysis
showed that age, body temperature, white blood cell count, C-
reactive protein and PCT were significantly greater in patients
with critical illness, as were associated immunocompromised
status and altered haemodynamic or renal function at ED
assessment. Stepwise logistic regression analysis showed
that three variables were significantly associated with critical
illness: PCT of 2 μg/l or greater, heart rate above 120 beats/
min, and creatininaemia of 120 μmol/l or greater (Table 4).
Moreover, there was a correlation between the magnitude of
elevation in PCT and the likelihood of subsequent critical ill-
ness or death (Figure 3). Indeed, 51% of patients with PCT
concentrations of 5 μg/l or greater were deceased at day 30
or admitted to the ICU, as compared with 13% of patients in
whom PCT concentration was not elevated.
Discussion
The main purpose of the present study was to test the effi-
ciency of PCT in identifying bacterial/parasitic episodes
among febrile adult patients presenting to an ED. Therefore, a
limitation of the present study is that we did not include febrile
outpatients who were normothermic in the ED because of
ongoing antipyretic drugs treatment. Second, we did not study
PCT kinetics in infected patients with low initial PCT levels. In
practice, however, ED physicians must base their biologic
evaluation on a single blood sample and not on sequential
samples. Unlike the majority of studies published to date on
the PCT assay, we did not focus on an organ-specific infec-
tion, as well we did not exclude immunocompromised patients
[5-10]. Fever does not represent a predominant symptom
among patients attending an ED, accounting for only 1.7% to
2.5% of them [11,12]. During the duration of the present
study, the patients included accounted for 1.3% of the total
number of medical emergency consultations, assuming that
the majority of febrile patients had actually been screened. The
population that we studied probably reflects the broad aetio-
logical diagnoses and situations that may confront emergency
physicians when they attend to adult febrile patients.
The major limitation of our study is the choice of gold standard
against which to assess the aetiology of febrile episodes. We
considered expert diagnosis to be more suitable, because a
significant proportion of bacterial febrile episodes is never
Figure 2
Values of biomarkers in the different febrile groups: none (noninfec- tious), and viral, bacterial and parasitic infections Values of biomarkers in the different febrile groups: none (noninfec-
tious), and viral, bacterial and parasitic infections. (a) Procalcitonin 
(PCT). (b) C-reactive protein (CRP). Data are presented in a semi-loga-
rithm scale. Each dark circle indicates a patient. Dark squares repre-
sent medians (95% confidence interval) and dotted lines the optimal 
threshold determined on receiver operating characteristic curve: 0.2 
μg/l for PCT and 40 mg/l for CRP.Critical Care    Vol 11 No 3    Hausfater et al.
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confirmed microbiologically in the setting of ED care. Although
such methodology might have led to misclassification, agree-
ment between the two experts was good (89% to 93%).
PCT at a cutoff value of 0.2 μg/l exhibited a sensitivity of 0.77
and a specificity of 0.59 for identifying patients with bacterial/
parasitic infection, and its efficiency was comparable to that of
the emergency physician (Table 2). Moreover, among the bio-
logic variables evaluated, PCT was found to be the most pre-
dictive of bacterial/parasitic infection, with an odds ratio of
4.54 (Table 3). In a previous study, the same PCT cutoff value
was associated with a 0.62 sensitivity and 0.88 specificity [2].
However, the population studied was not the same as that in
the present study, in which only feverish patients were
included; therefore, the prevalence of bacterial infection in that
previous study was much lower. Moreover, in that previous
study [2] we used a less sensitive assay for PCT measurement
(LUMitest PCT [Brahms Diagnostica]; functional sensitivity
0.33 μg/l), which could have underestimated the number of
patients with low concentrations. Similarly, using the same
less sensitive assay (LUMItest) and a PCT cutoff value of 0.6
μg/L, Chan and coworkers [13] reported a 0.69 sensitivity and
a 0.65 specificity for PCT in identifying infection among unse-
lected atraumatic patients admitted via their ED. In a pediatric
population, Gendrel and colleagues [4] reported on the ability
of a PCT assay to identify bacterial infection, and found a 0.83
sensitivity and a 0.93 specificity with a cutoff PCR value of 1
μg/l. However, that study was restricted to febrile children in
whom a responsible pathogen was identified, leading to exclu-
sion of more than 50% of patients initially screened. In another
pediatric study conducted in children presenting with body
temperature above 38°C [14], sensitivity and specificity of
PCT were 0.65 and 0.94, respectively, for a 0.53 μg/l cutoff.
The lower specificity that we report (0.59) may have two pri-
mary explanations. First, we retained a low cutoff value for PCT
assay (0.2 μg/l). This cutoff value was retained based on sta-
tistical considerations because it was the optimal compromise
between sensitivity and specificity on the ROC curve.
However, in practice the threshold must be suited to the clini-
cal context. For example, on one hand, a 0.1 μg/l cutoff may be
useful in immunocompromised patients to screen for bacterial
infection, although it may lead to a significant proportion of
false-positive results (specificity 0.32; Table 2). On the other
hand, a 2 μg/l threshold exhibited excellent specificity for bac-
terial infection (0.93), but it lacked sensitivity (0.36), which
would lead to under-diagnosis a large proportion of infected
patients (Table 2). Because a 0.25 μg/l threshold was
reported to be useful within the context of respiratory tract
infection [5,15] and in the ED setting [2], our choice of a 0.2
μg/l cutoff in the present study is a rational one. Finally,
because PCT determination in ED is performed early in the
course of infection, a low threshold may be more appropriate
in this setting than the higher threshold that could be used in
the ICU. However, further studies are required to determine
precisely the optimal PCT thresholds for application in febrile
patients presenting to the ED. The second reason that may
account for the the lower specificity we report here is that of
the 31 patients with no bacterial/parasitic infection but with
raised PCT concentrations (false positives), 12 had diseases
that have previously been shown to be associated with ele-
vated PCT, namely acute pancreatitis, environmental heat-
stroke and haemophagocytic syndrome [4,16,17].
The PCT assay was particularly efficient at identifying critical
bacterial/parasitic infections. First, the sensitivity of PCT was
higher (0.87) for the diagnosis of bacteraemic infection, and a
Table 2
PCT and CRP versus emergency physician judgement in diagnosing bacterial/parasitic infection
Test and cutoff Sensitivity (95% CI) Specificity (95% CI) PPV (95% CI) NPV (95% CI) Accuracy (95% CI)
CRP
≥ 5 mg/l 0.96 (0.91–0.98) 0.16 (0.09–0.26) 0.71 (0.65–0.77) 0.63 (0.41–0.81) 0.71 (0.64–0.76)
≥40 mg/l 0.76 (0.69–0.82)* 0.62 (0.51–0.72) 0.81 (0.74–0.87) 0.54 (0.44–0.64)* 0.71 (0.65–0.77)
≥100 mg/l 0.54 (0.46–0.62) 0.90 (0.82–0.95) 0.93 (0.85–0.96) 0.47 (0.39–0.56) 0.65 (0.59–0.71)
PCT
≥0.1 μg/l 0.90 (0.85–0.94) 0.32 (0.22–0.43) 0.74 (0.68–0.80) 0.60 (0.47–0.74) 0.72 (0.66–0.77)
≥0.2 μg/l 0.77 (0.70–0.82)* 0.59 (0.48–0.70) 0.80 (0.74–0.86) 0.54 (0.43–0.64)* 0.71 (0.65–0.77)
≥0.5 μg/l 0.63 (0.55–0.70) 0.79 (0.68–0.87) 0.87 (0.80–0.92) 0.49 (0.40–0.58) 0.68 (0.62–0.73)
≥2 μg/l 0.36 (0.30–0.44) 0.93 (0.85–0.97) 0.92 (0.83–0.97) 0.40 (0.33–0.47) 0.54 (0.48–0.60)
≥5 μg/l 0.23 (0.17–0.30) 0.99 (0.93–1.00) 0.97 (0.87–0.99) 0.37 (0.30–0.44) 0.46 (0.40–0.53)
Emergency physician 0.85 (0.79–0.90) 0.57 (0.45–0.67) 0.81 (0.75–0.86) 0.63 (0.51–0.74) 0.76 (0.70–0.81)
Shown is a comparison of performance of procalcitonin (PCT) and C-reactive protein (CRP) with emergency physician for the diagnosis of 
bacterial/parasitic infection, with the 'gold standard' being experts diagnosis. *P < 0.05, versus emergency physician. CI, confidence interval; 
NPV, negative predictive value; PPV, positive predictive value.Available online http://ccforum.com/content/11/3/R60
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PCT value under 0.2 μg/l made bloodstream infection unlikely
(negative predictive value 0.92). These findings are in accord-
ance with a previous study [18] reporting a negative predictive
value of 0.99 for a PCT cutoff value of 0.4 μg/l, when compar-
ing bacteraemic with nonbacteraemic infectious episodes
among patients hospitalized for community-acquired infection.
Using the same 0.2 μg/l cutoff value as in the present study,
Caterino and coworkers [19] identified a 0.93 sensitivity and
a 0.38 specificity for PCT assay in detecting bacteraemia in
older ED patients. Second, the magnitude of the rise in PCT
correlated with the severity of infectious disease (Figure 3).
Indeed, more than half of the patients with PCT above 5 μg/l
in the emergency room were either transferred to the ICU or
had died by day 30. For five patients initially admitted to a med-
ical ward but who subsequently died or were admitted to the
ICU, the availability of PCT results in the emergency room
might have helped the emergency physician to identify the
severity of illness and to opt for ICU admission. The efficiency
of PCT in predicting critical illness has already been reported
in pediatric, adult ICU and, less frequently, ED populations,
with cutoff values between 3 and 33 μg/L [1-3,20-23]. How-
ever, because most previous studies were conducted in an
ICU setting, our study does support the usefulness of PCT in
the emergency room in identifying those patients in whom
early ICU admission may be justified. The place of PCT
together with severity scores such as the Pneumonia Severity
Index must be defined. Early assessment based on PCT find-
ings might be of paramount importance, because early goal-
directed therapy has been proven to confer significant benefit
with respect to outcome in patients with severe sepsis and
septic shock [24].
Overall, emergency physician judgement appeared to be as
efficient as or better than the PCT assay (Table 2). However,
usual clinical practice was rather conflicting, in that 193 (83%)
patients left the emergency room with antibiotics, although
only 173 (71%) were considered to have bacterial/parasitic
infection from the emergency physician's point of view. Simi-
larly, seven out of 20 (35%) patients who were considered by
the emergency physician to have acute viral infection left the
emergency room with antibiotics. Interestingly, the results of
two of the three quantitative variables significantly associated
with bacterial/parasitic infection were known by emergency
physicians and could theoretically have influenced their judge-
ment of etiology. Conversely, one might speculate that knowl-
edge of PCT measurement in some cases of intermediate pre-
Table 3
Comparison of patients with or without bacterial/parasitic infection (univariate analysis) and identification of variables predictive 
of bacterial/parasitic infection after stepwise logistic regression analysis (multivariate analysis)
Variable Univariate analysis Multivariate analysis
Nonbacterial/parasitic (n = 76) Bacterial/parasitic (n = 167) P Odds ratio [95% CI] P
Sex (male) 40 (47%) 94 (44%) NS
Age (year) 54 ± 25 57 ± 19 NS
Temperature (°C) 39.1 ± 0.6 39.2 ± 0.6 NS
Heart rate (beats/min) 101 ± 21 107 ± 20 0.03
Systolic arterial blood pressure (mmHg) 131 ± 23 127 ± 22 NS
Immunodepression 20 (26%) 51 (30%) NS
Headache 27 (35%) 37 (22%) 0.04
Myalgia 23 (30%) 30 (18%) 0.04
Emergency physician diagnosis 70 (29%) 173 (71%) < 0.001 7.54 [3.60–15.82] < 0.001
Haemoglobin level (mg/l) 128 ± 19 125 ± 23 NS
White blood cell count (/mm3) 8060 ± 3777 11688 ± 8039 < 0.001
Neutrophil leukocytes ≥ 7,500/mm3 21 (28%) 88 (54%) < 0.001 3.17 [1.52–6.62] 0.002
Platelet count (103/mm3) 198 ± 90 204 ± 99 NS
Creatinine (μmol/l) 97 ± 39 118 ± 97 NS
PCT (μg/l) 0.7 ± 2.2 11.1 ± 39.0 < 0.001
PCT ≥ 0.2 μg/l 31 (41%) 128 (77%) < 0.001 4.54 [2.19–9.39] < 0.001
CRP (mg/l) 39 ± 48 150 ± 128 < 0.001
CRP ≥ 40 mg/l 28 (38%) 122 (76%) < 0.001 3.67 [1.79–7.53] < 0.001
Data are expressed as mean ± standard deviation or number (%). For multivariate analysis all other P values were NS. CI, confidence interval; 
CRP, C-reactive protein; NS, not significant; PCT, procalcitonin.Critical Care    Vol 11 No 3    Hausfater et al.
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test probability may turn into high post-test probability of bac-
terial infection and therefore more suitable care. Biological
markers must be considered diagnostic and prognostic tools
that should assist physicians in their clinical practice, but they
should not replace medical judgement. Within the context of
infectious diseases, two recent studies [5,15] pointed out the
effectiveness of the PCT assay in safely reducing the number
of unnecessary antibiotic prescriptions for management of res-
piratory tract infections. Although our data support the need
for efficient bacterial and viral markers to improve rational use
of antibiotics, interventional studies, in which antimicrobial
therapy is guided by a marker and in which the primary meas-
ure of efficacy is outcome, should be encouraged.
Conclusion
Within the context of febrile adult patients presenting to an ED,
PCT assay at a 0.2 μg/l threshold can help physicians to iden-
tify bacterial/parasitic infections. Whether this can back up
therapeutic decisions must be investigated in interventional
studies. PCT measurement in the emergency room could con-
tribute to the early identification of critical illness. Emergency
febrile patients with PCT above 5 μg/l should be carefully
monitored to identify severe sepsis or septic shock criteria.
Table 4
Univariate analysis of patients deceased at day 30 or admitted to ICU versus all others patients, and identification of variables 
associated with critical illness after stepwise logistic regression analysis
Univariate analysis Multivariate analysis
Group II (n = 166) Group I (n = 55) P Odds ratio
[95% CI]
P
Male sex 91 (54%) 33 (60%) NS
Age (year) 55 ± 22 65 ± 16 0.001 1.02 [1.00–1.04] 0.013
Temperature (°C) 39.1 ± 0.6 39.4 ± 0.7 0.01
Heart rate > 120 beats/min 33 (20%) 19 (34%) 0.03 2.36 [1.22–4.96] 0.02
Systolic blood pressure < 90 mmHg 1 (1%) 3 (5%) 0.047
White blood cell count (/mm3) 10272 ± 7195 26601 ± 83080 0.01
Previous antibiotic treatment 24 (14%) 7 (13%) NS
Antibiotics initiated in ED 129 (79%) 47 (85%) NS
Immunocompromised status 44 (26%) 24 (44%) 0.02
Positive blood culture or thick smear 
(Plasmodium)
33 (20%) 18 (33%) NS
Platelet count (103/mm3) 199 ± 93 194 ± 102 NS
Haemoglobin level (mg/l) 12.8 ± 2 12 ± 2.8 0.02
CRP (mg/l) 103 ± 112 149 ± 144 0.01
Creatinine ≥ 120 μmol/l 29 (17%) 23 (42%) < 0.001 2.16 [1.04–4.49] 0.04
PCT μg/l 3.1 ± 10.8, 0.3 [0.3–0.5], (0–115) 24.3 ± 63.7, 1.9 [0.8–4.7], (0–316) < 0.001
PCT ≥ 2 μg/L 36 (22%) 27 (49%) < 0.001 2.51 [1.25–5.04] 0.001
Shown is a univariate analysis comparing group I (patients deceased at day 30 or admitted to intensive care unit [ICU]) and group II (all other 
patients) and identification of variables associated with critical illness (ICU admission or death) after stepwise logistic regression analysis. Data 
are expressed as number of patients (%), mean ± standard deviation, median [95% CI] (extrems). For multivariate analysis all other P values were 
NS. CI, confidence interval; CRP, C-reactive protein; ED, emergency department; NS, not significant; PCT, procalcitonin.
Figure 3
Relation between critical illness (death or ICU transfer) and PCT value  range Relation between critical illness (death or ICU transfer) and PCT value 
range. A total of 55 patients had critical illness, 31 of which were inten-
sive care unit (ICU) transfers and 30 died (including six patients admit-
ted to the ICU). PCT, procalcitonin.Available online http://ccforum.com/content/11/3/R60
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Key messages
￿  The optimal PCT threshold in adult febrile patients in 
the ED may be 0.2 μg/l.
￿  PCT is an independent variable that can predict 
whether a febrile episode has a bacterial origin.
￿  PCT, at a threshold of 2 μg/l, is independently associ-
ated with critical illness.